Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 391 AL 405

Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms

Ballard C, Youakim JM, Coate B, Stankovic S.

J Prev Alzheimers Dis. 2019;6(1):27-33. doi: 10.14283/jpad.2018.30.

Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2

Bahn G, Jo DG.

Neuromolecular Med. 2019 Mar;21(1):1-11. doi: 10.1007/s12017-018-08523-5. Epub 2019 Jan 7.

Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)

Włodarek D.

Nutrients. 2019 Jan 15;11(1):169. doi: 10.3390/nu11010169.

Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease

Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA.

Int J Mol Sci. 2019 Feb 8;20(3):719. doi: 10.3390/ijms20030719.

Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia

Haenseler W, Rajendran L.

Stem Cells. 2019 Jun;37(6):724-730. doi: 10.1002/stem.2995. Epub 2019 Mar 10.

Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality

Hudry E, Vandenberghe LH.

Neuron. 2019 Mar 6;101(5):839-862. doi: 10.1016/j.neuron.2019.02.017.

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH.

J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13.

Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review

Dinda B, Dinda M, Kulsi G, Chakraborty A, Dinda S.

Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8.

An Overview of Primary Dementias as Clinicopathological Entities

Salardini A.

Semin Neurol. 2019 Apr;39(2):153-166. doi: 10.1055/s-0039-1683445. Epub 2019 Mar 29.

Recent Advances in Apoptosis: THE Role of Hydrazones

Çıkla-Süzgün P, Küçükgüzel ŞG.

Mini Rev Med Chem. 2019;19(17):1427-1442. doi: 10.2174/1389557519666190410125910.

Emerging drugs for progressive supranuclear palsy

Giagkou N, Stamelou M.

Expert Opin Emerg Drugs. 2019 Jun;24(2):83-92. doi: 10.1080/14728214.2019.1609450. Epub 2019 May 20.

Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases

Nishibori M, Mori S, Takahashi HK.

J Pharmacol Sci. 2019 May;140(1):94-101. doi: 10.1016/j.jphs.2019.04.006. Epub 2019 May 4.

Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models

Feng ST, Wang ZZ, Yuan YH, Sun HM, Chen NH, Zhang Y.

Pharmacol Res. 2019 Aug;146:104336. doi: 10.1016/j.phrs.2019.104336. Epub 2019 Jul 2.

Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease

Nakajima A, Ohizumi Y.

Int J Mol Sci. 2019 Jul 10;20(14):3380. doi: 10.3390/ijms20143380.

Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles: The culprit of Alzheimer and Parkinson's diseases

Calderón-Garcidueñas L, Reynoso-Robles R, González-Maciel A.

Environ Res. 2019 Sep;176:108574. doi: 10.1016/j.envres.2019.108574. Epub 2019 Jul 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias